Ain's (TYO:9627) profit attributable to owners of the parent surged 39% to 10.2 billion yen for the nine months ended Jan. 31 from 7.36 billion yen a year earlier.

The pharmaceutical group's basic profit per share increased to 291.15 yen from 210.05 yen a year ago, according to a Tokyo bourse filing on Tuesday.

Net sales jumped 41% to 474.9 billion yen from 336.8 billion yen in the prior year.

For the fiscal year ending April 30, the company expects attributable profit of 13.5 billion yen, profit per share of 384.91 yen, and net sales of 646 billion yen.

Ain plans to pay a year-end dividend of 80.00 yen per share for the fiscal year ending April 30, unchanged from the 80.00 yen per share paid in the prior fiscal year.